Sexual health

When Antidepressant Sexual Side Effects Don't Go Away

Save

Most people whose sex drive or sensation changes on an antidepressant get better after adjusting or stopping it. This covers the much less common experience of symptoms that don't resolve — what's actually known about post-SSRI sexual dysfunction, what isn't, how it's told apart from ordinary depression-related low libido or an unrelated medical cause, and what a realistic conversation with a clinician about it looks like.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What is post-SSRI sexual dysfunction?

Post-SSRI sexual dysfunction describes genital numbness, reduced arousal, low desire, or difficulty reaching orgasm that continues well after a person has fully stopped taking an SSRI or SNRI antidepressant, rather than the sexual side effects that many people experience while actively taking one and that typically improve with a dose change or after stopping. It's a pattern clinicians and researchers are actively trying to understand better, not a settled diagnosis with a clear test.

Sexual side effects while on an SSRI or SNRI are common and well documented — reduced desire, delayed orgasm, and genital numbness are recognized effects of these medications for many people who take them. SSRIs and SNRIs sit alongside a longer list of medications that cause ED and other sexual side effects, a connection that's well established for many drug classes generally 1. What makes persistent, post-discontinuation symptoms different is the timing: by definition, they're still present after the drug should have cleared the body entirely, which is what separates PSSD from an ordinary, expected side effect that simply hasn't faded yet. For most people, sexual side effects from an antidepressant resolve once the medication is stopped or adjusted; persistent symptoms are the less common experience, not the expected one.

How much is actually known — and how much isn't

The honest answer is that PSSD is not fully understood. There's no blood test or imaging finding that confirms it, no agreed-upon way to measure how common it is, and no single accepted explanation for why symptoms persist in some people and not others after the same medication and the same length of use.

What exists is a body of case reports and patient accounts describing genital numbness, blunted arousal, or absent orgasm that continued for months or years after stopping an SSRI or SNRI, alongside ongoing research trying to work out how common this actually is and what's happening physiologically. Some researchers have proposed that the medication may cause a lasting change in how certain nerve pathways or receptors involved in sexual response function, but this remains a working theory rather than a confirmed mechanism. Being upfront about that uncertainty isn't a way of dismissing the experience — it's the accurate state of the evidence, and it's also why a clinician working through a case of persistent symptoms has to rule out other explanations carefully rather than relying on a specific test for PSSD itself.

How it's told apart from other causes of low desire and low sensation

Persistent sexual difficulty after stopping an antidepressant isn't automatically PSSD, because depression itself is a well-recognized cause of reduced desire and sexual difficulty, independent of any medication used to treat it, and several other common conditions produce a similar pattern. Sorting through these possibilities is a routine part of evaluating symptoms like this, medication history or not.

In women, clinical guidance for evaluating low desire, low arousal, or difficulty with orgasm considers a wide range of contributors — desire, arousal, orgasm, and pain are assessed as related but distinct categories of female sexual dysfunction, since it's common for more than one to be involved and for the driver to be something other than a past medication 2. A recurrence or worsening of the underlying depression or anxiety that the antidepressant was originally treating can itself blunt sexual desire, which is one reason a mood assessment is part of working through these symptoms, separate from a medication review. New erectile difficulty in men deserves its own careful look too, including ruling out the vascular and metabolic causes involved in a lot of erectile dysfunction, since ed and clogged arteries can produce a similar-looking picture that has nothing to do with a medication taken in the past 3.

What a careful evaluation actually looks like

An evaluation for possible PSSD starts by ruling out the more common explanations first: a return of depression or anxiety, a different medication or medical condition, a hormonal shift, or a relationship factor, since there's no test that confirms PSSD directly. Only once those have been considered does a clinician and patient work through what persistent symptoms mean and what realistic next steps look like.

Bringing a specific, detailed timeline is more useful here than almost anywhere else in sexual health: when the antidepressant was started, at what dose, when it was stopped or changed, and exactly when symptoms began relative to those changes. Bloodwork to check hormone levels and screen for other medical contributors is a reasonable part of this evaluation, alongside a mood assessment, since distinguishing depression-related low desire from medication-related symptoms otherwise depends heavily on the history rather than a single test. A clinician who takes the report of persistent symptoms seriously, rather than assuming it must be psychological or brushing past it, is doing the evaluation correctly — dismissing the possibility outright isn't more scientifically sound than accepting it uncritically; both skip the actual work of ruling things in and out.

What can help, honestly

Because the evidence base for PSSD specifically is limited, there's no single treatment shown to reliably reverse it, and it's worth being skeptical of anything promising a guaranteed fix. What genuinely helps varies by person and often focuses on what can be influenced even while the underlying mechanism stays uncertain.

For some people, the anxiety and distress that build up around persistent sexual symptoms become their own separate problem, layered on top of the physical experience — a pattern with real overlap with sexual performance anxiety, and one that a sex therapist or counselor can address directly even when the original symptoms don't fully resolve. Addressing sleep, general health, and relationship communication doesn't reverse PSSD itself, but each is a legitimate part of overall sexual function and worth attending to regardless. Whether or when to start, change, or stop any antidepressant is a decision that belongs with the prescribing clinician, weighed against the reason the medication was started in the first place — untreated depression or anxiety carries its own serious risks, which is part of what makes this a genuinely difficult conversation rather than a simple one.

Deciding what to do next

There's no way to predict in advance who will experience lasting sexual side effects from an SSRI or SNRI, which makes this a difficult, individual conversation rather than one with a universal answer. What's useful is naming the symptoms specifically and early, rather than assuming they'll pass or that nothing can be done about them either way.

A conversation with the prescribing clinician about the full picture — how well the medication is working for the original condition, how much the sexual symptoms are affecting quality of life, and what alternatives exist — is the starting point, not a decision to make alone. Female sexual dysfunction and its overlapping categories of desire, arousal, orgasm, and pain give a useful framework for describing what's actually changed, even outside the specific question of medication, since precise language helps a clinician sort through the possibilities faster. Persistent symptoms are also a legitimate reason to seek a second opinion or a referral to a specialist in sexual medicine, particularly if the first conversation felt rushed or dismissive — this is an area where clinical understanding is still evolving, and being taken seriously is a reasonable thing to expect.

Common questions

No. Sexual side effects while actively taking an SSRI or SNRI are common and usually improve with a dose change or after stopping the medication. PSSD specifically describes symptoms — genital numbness, low desire, or difficulty with arousal or orgasm — that persist well after the drug has fully left the body, a much less common and less well-understood pattern.

This isn't reliably known. There's no standardized way to diagnose it and no large study establishing exactly how often it occurs, so any specific number should be treated with caution. What's clear is that most people who experience sexual side effects on an SSRI or SNRI see them resolve, and persistent symptoms after stopping are the less common outcome.

Yes, and that possibility is worth taking seriously rather than assuming the medication is automatically responsible. Depression and anxiety are themselves well-recognized causes of reduced desire and sexual difficulty, independent of treatment, which is why a mood assessment is a standard part of evaluating symptoms like this rather than an afterthought.

That decision belongs with the prescribing clinician, not something to work out alone, since abruptly changing or stopping an antidepressant carries its own risks, including a return of the condition it was treating. A conversation about the full picture — how well the medication is working, how the symptoms are affecting quality of life, and what alternatives exist — is the appropriate next step.

No treatment is currently established as reliably reversing it, and that's an honest limitation of the evidence rather than a reason to give up on addressing it. Some people find that ruling out and treating other contributors, along with support for the anxiety that often builds up around persistent symptoms, meaningfully improves quality of life even without a single fix for the underlying pattern.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to loop in a clinician about persistent sexual side effects

  • —New, severe depression, hopelessness, or thoughts of self-harm, especially if considering stopping medication on your own
  • —Sudden genital numbness or sexual changes with no connection to any medication change
  • —Symptoms that began immediately after starting a new prescription other than an antidepressant
  • —A significant, unplanned change or lapse in taking a prescribed antidepressant

Thoughts of self-harm or that life isn't worth living are a reason to call or text 988, the Suicide and Crisis Lifeline, right away.

This article is general health education, not medical advice. It doesn't recommend starting, changing, or stopping any medication — those decisions belong with the prescribing clinician, weighed against the reason the medication was started.

References

  1. 1.National Institute of Diabetes and Digestive and Kidney Diseases (NIH) (2017). Symptoms & Causes of Erectile Dysfunction. NIDDK (niddk.nih.gov). link ✓Supports that ED and related sexual side effects can be caused by certain medicines among other factors, used here narrowly to establish that medications, including antidepressants, are a recognized class of cause for sexual side effects generally.
  2. 2.American College of Obstetricians and Gynecologists (2019). Female Sexual Dysfunction: ACOG Practice Bulletin, Number 213. Obstetrics & Gynecology 134(1):e1-e18. PMID 31241595 ✓Supports the ACOG framework evaluating female sexual dysfunction across desire, arousal, orgasm, and pain as related but distinct categories, used here to frame how persistent symptoms after antidepressant use are evaluated among other possible contributors.
  3. 3.Gandaglia G, Briganti A, Jackson G, et al. (2014). A systematic review of the association between erectile dysfunction and cardiovascular disease. European Urology 65(5):968-978. doi:10.1016/j.eururo.2013.08.023 ✓Supports that erectile dysfunction and cardiovascular disease share endothelial dysfunction as a common mechanism, used here narrowly to note that new erectile difficulty warrants ruling out vascular causes rather than assuming it is medication-related by default.

3 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library